Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis

• Published in: World journal of gastroenterology : WJG Vol. 23; no. 2; pp. 336 - 344
• Main Authors: Cayzeele-Decherf, Amélie, Pélerin, Fanny, Leuillet, Sébastien, Douillard, Benoit, Housez, Béatrice, Cazaubiel, Murielle, Jacobson, Gunnard K, Jüsten, Peter, Desreumaux, Pierre
• Format: Journal Article
• Language: English
• Published: United States Baishideng Publishing Group Inc 14.01.2017
• Subjects: Abdominal Pain - drug therapy; Abdominal Pain - etiology; Adult; Biological Therapy - methods; Constipation - drug therapy; Constipation - etiology; Defecation - drug effects; Female; Flatulence - drug therapy; Flatulence - etiology; Humans; Irritable Bowel Syndrome - complications; Irritable Bowel Syndrome - drug therapy; Male; Meta-Analysis; Middle Aged; Probiotics - therapeutic use; Randomized Controlled Trials as Topic; Saccharomyces cerevisiae - physiology; Treatment Outcome; Abdominal pain; Probiotics; Constipation; Saccharomyces cerevisiae; Irritable bowel syndrome

AIM To confirm previous conclusions on Saccharomyces cerevisiae(S. cerevisiae) CNCM I-3856 for irritable bowel syndrome(IBS) management.METHODS An individual patient data meta-analysis was performed on two randomized clinical trials studying the effect of S. cerevisiae CNCM I-3856 supplementation on...